4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow DBV Technologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects DBV712 IHRP - Peanut Allergy | Phase 1 | Completed | DBV Technologies | 27 | 2017-11-24 | 2019-07-26 |
| Viaskin Pertussis Vaccine Trial Viaskin PT 25 mcg, Viaskin PT 50 mcg, Viaskin PT Placebo - Whooping Cough | Phase 1 | Completed | DBV Technologies | 102 | 2016-09-05 | 2020-03-02 |
| Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Viaskin Milk 150 mcg, Viaskin Milk 300 mcg, Viaskin Milk 500 mcg - Food Allergy | Phase 1 / Phase 2 | Completed | DBV Technologies | 198 | 2014-11-01 | 2024-11-20 |
| Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy Whole peanut extract, Placebo formulation - Peanut Allergy | Phase 1 | Completed | DBV Technologies | 100 | 2010-07-01 | 2012-03-23 |
Food Hypersensitivity (2) · Peanut Hypersensitivity (2) · Hypersensitivity, Immediate (1) · Milk Hypersensitivity (1) · Whooping Cough (1)
Boostrix (1)
United States (3) · Canada (1) · Switzerland (1)